Fengzhou Li

797 total citations
26 papers, 542 citations indexed

About

Fengzhou Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fengzhou Li has authored 26 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Fengzhou Li's work include Lung Cancer Treatments and Mutations (7 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (4 papers). Fengzhou Li is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (4 papers). Fengzhou Li collaborates with scholars based in China, Taiwan and Japan. Fengzhou Li's co-authors include Chundong Gu, Lei Fang, Shilei Zhao, Wendan Yu, Wei Guo, Wuguo Deng, Yixiang Zhang, Songyu Li, Zhuoshi Li and Tao Guo and has published in prestigious journals such as Biochemical and Biophysical Research Communications, IEEE Access and Frontiers in Immunology.

In The Last Decade

Fengzhou Li

26 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengzhou Li China 14 302 157 149 112 93 26 542
Shenghui Qin China 12 297 1.0× 108 0.7× 156 1.0× 74 0.7× 56 0.6× 27 476
Reid Loveless United States 11 332 1.1× 85 0.5× 137 0.9× 94 0.8× 127 1.4× 14 507
Heng‐Ying Pu China 9 378 1.3× 70 0.4× 201 1.3× 110 1.0× 80 0.9× 10 491
Xipeng Zhang China 14 293 1.0× 160 1.0× 213 1.4× 70 0.6× 81 0.9× 38 572
Zehua Wang China 13 275 0.9× 185 1.2× 187 1.3× 103 0.9× 126 1.4× 32 562
Laura Mannarino Italy 10 214 0.7× 188 1.2× 104 0.7× 120 1.1× 119 1.3× 24 498
Taohua Yue China 15 330 1.1× 144 0.9× 174 1.2× 143 1.3× 56 0.6× 24 607
Hyeryeong Kim South Korea 6 328 1.1× 221 1.4× 182 1.2× 105 0.9× 54 0.6× 10 583

Countries citing papers authored by Fengzhou Li

Since Specialization
Citations

This map shows the geographic impact of Fengzhou Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengzhou Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengzhou Li more than expected).

Fields of papers citing papers by Fengzhou Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengzhou Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengzhou Li. The network helps show where Fengzhou Li may publish in the future.

Co-authorship network of co-authors of Fengzhou Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fengzhou Li. A scholar is included among the top collaborators of Fengzhou Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengzhou Li. Fengzhou Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Fengzhou, et al.. (2024). Integrating AutoGluon for Real-Time Monitoring and Classification of Dental Equipment Performance. IEEE Access. 13. 2844–2854. 1 indexed citations
2.
Zhang, Yixiang, et al.. (2024). Genomic heterogeneity of multiple synchronous lung cancers in Chinese population. Cancer Medicine. 13(2). e6928–e6928. 2 indexed citations
3.
Song, Ling, et al.. (2024). Knowledge mapping of immunotherapy in cervical carcinoma: a bibliometric analysis (2000-2023). Frontiers in Immunology. 14. 1328103–1328103. 3 indexed citations
4.
Yang, Tao, et al.. (2024). Accuracy of robotic-assisted surgery for immediate implant placement in posterior teeth: a retrospective case series. BMC Oral Health. 24(1). 1263–1263. 4 indexed citations
5.
Li, Xuejing, et al.. (2023). Xenogeneic collagen matrix versus free gingival graft for augmenting keratinized mucosa around posterior mandibular implants: a randomized clinical trial. Clinical Oral Investigations. 27(5). 1953–1964. 18 indexed citations
7.
8.
Wang, Jin, et al.. (2021). Autocrined leptin promotes proliferation of non-small cell lung cancer (NSCLC) via PI3K/AKT and p53 pathways. Annals of Translational Medicine. 9(7). 568–568. 16 indexed citations
9.
Wang, Jin, Yixiang Zhang, Shilei Zhao, et al.. (2021). Genetic Mutation Analysis in Small Cell Lung Cancer by a Novel NGS‐Based Targeted Resequencing Gene Panel and Relation with Clinical Features. BioMed Research International. 2021(1). 3609028–3609028. 11 indexed citations
10.
Xie, Qiang, Shilei Zhao, Wenzhi Liu, et al.. (2021). YBX1 Enhances Metastasis and Stemness by Transcriptionally Regulating MUC1 in Lung Adenocarcinoma. Frontiers in Oncology. 11. 702491–702491. 18 indexed citations
12.
Yu, Wendan, Yi‐Jun Hua, Huijuan Qiu, et al.. (2020). PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer. Cell Death and Disease. 11(7). 506–506. 120 indexed citations
13.
Guo, Ping, Fengzhou Li, Xiu Shan, et al.. (2020). Importin 13 promotes NSCLC progression by mediating RFPL3 nuclear translocation and hTERT expression upregulation. Cell Death and Disease. 11(10). 879–879. 9 indexed citations
14.
Zhao, Shilei, Fengzhou Li, Tao Guo, et al.. (2020). New additional scoring formula on the Pathological Features in Stage I Lung Adenocarcinoma Patients: Impact on Survival. International Journal of Medical Sciences. 17(13). 1871–1878. 2 indexed citations
15.
Cui, Yanwei, Fengzhou Li, Qiang Xie, et al.. (2020). YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC. Cell Death and Disease. 11(6). 476–476. 33 indexed citations
16.
Sun, Ying, Wei Sun, Ning Yang, et al.. (2019). The effect of core fucosylation-mediated regulation of multiple signaling pathways on lung pericyte activation and fibrosis. The International Journal of Biochemistry & Cell Biology. 117. 105639–105639. 10 indexed citations
17.
Cui, Yanwei, Lei Zhao, Shilei Zhao, et al.. (2019). MicroRNA-30e inhibits proliferation and invasion of non-small cell lung cancer via targeting SOX9. Human Cell. 32(3). 326–333. 16 indexed citations
18.
Fang, Lei, Fengzhou Li, & Chundong Gu. (2019). GDF-15: A Multifunctional Modulator and Potential Therapeutic Target in Cancer. Current Pharmaceutical Design. 25(6). 654–662. 28 indexed citations
19.
Guo, Tao, Jing Kong, Yang Liu, et al.. (2017). Transcriptional activation of NANOG by YBX1 promotes lung cancer stem-like properties and metastasis. Biochemical and Biophysical Research Communications. 487(1). 153–159. 29 indexed citations
20.
Zhao, Shilei, Yan Wang, Tao Guo, et al.. (2016). YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma. Oncotarget. 7(50). 82139–82157. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026